4.5 Article

Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Newborn screening for SMA in Southern Belgium

Francois Boemer et al.

NEUROMUSCULAR DISORDERS (2019)

Article Health Care Sciences & Services

Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives

Tamara Dangouloff et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)

Article Clinical Neurology

AVXS-101 (Onasemnogene Abeparvovec) for SMA 1: Comparative Study with a Prospective Natural History Cohort

Samiah A. Al-Zaidy et al.

JOURNAL OF NEUROMUSCULAR DISEASES (2019)

Article Clinical Neurology

Nusinersen for SMA: expanded access programme

Michelle A. Farrar et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Clinical Neurology

Nusinersen in type 1 SMA infants, children and young adults: Preliminary results on motor function

Marika Pane et al.

NEUROMUSCULAR DISORDERS (2018)

Article Clinical Neurology

Nusinersen in patients older than 7 months with spinal muscular atrophy type 1 A cohort study

Karolina Aragon-Gawinska et al.

NEUROLOGY (2018)

Article Medicine, General & Internal

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

R. S. Finkel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Clinical Neurology

Natural history of infantile-onset spinal muscular atrophy

Stephen J. Kolb et al.

ANNALS OF NEUROLOGY (2017)